CLEC16A-NTAN1 Fusion FISH Probe
The CLEC16A-NTAN1 Fusion FISH Probe is used to confirm a fusion of the CLEC16A and NTAN1 genes. The fusion of the CLEC16A and NTAN1 genes has been associated with Uterine Corpus Endometrial Carcinoma. These probes are FISH confirmed on normal peripheral blood in both interphase nuclei and metaphase spreads before shipment. Typical turnaround time for this product is 7-14 days after purchase.
** This product is for in vitro and research use only. This product is not intended for diagnostic use. Please note that both genes fall on the same chromosome and inter-chromosomal detection may be difficult to detect depending on the genes proximity to one another. Please consult our support staff before ordering this product to ensure that the probe can be designed to meet your specific needs.
| SKU | Test Kits | Buffer | Dye Color | Order Now |
|---|---|---|---|---|
| CLEC16A-NTAN1-20-ORGR (Standard Design) | 20 (40 μL) | 200 μL |
|
|
| CLEC16A-NTAN1-20-RERE | 20 (40 μL) | 200 μL |
|
|
| CLEC16A-NTAN1-20-REOR | 20 (40 μL) | 200 μL |
|
|
| CLEC16A-NTAN1-20-REGO | 20 (40 μL) | 200 μL |
|
|
| CLEC16A-NTAN1-20-REGR | 20 (40 μL) | 200 μL |
|
|
| CLEC16A-NTAN1-20-REAQ | 20 (40 μL) | 200 μL |
|
|
| CLEC16A-NTAN1-20-ORRE | 20 (40 μL) | 200 μL |
|
|
| CLEC16A-NTAN1-20-OROR | 20 (40 μL) | 200 μL |
|
|
| CLEC16A-NTAN1-20-ORGO | 20 (40 μL) | 200 μL |
|
|
| CLEC16A-NTAN1-20-ORAQ | 20 (40 μL) | 200 μL |
|
|
| CLEC16A-NTAN1-20-GORE | 20 (40 μL) | 200 μL |
|
|
| CLEC16A-NTAN1-20-GOOR | 20 (40 μL) | 200 μL |
|
|
| CLEC16A-NTAN1-20-GOGO | 20 (40 μL) | 200 μL |
|
|
| CLEC16A-NTAN1-20-GOGR | 20 (40 μL) | 200 μL |
|
|
| CLEC16A-NTAN1-20-GOAQ | 20 (40 μL) | 200 μL |
|
|
| CLEC16A-NTAN1-20-GRRE | 20 (40 μL) | 200 μL |
|
|
| CLEC16A-NTAN1-20-GROR | 20 (40 μL) | 200 μL |
|
|
| CLEC16A-NTAN1-20-GRGO | 20 (40 μL) | 200 μL |
|
|
| CLEC16A-NTAN1-20-GRGR | 20 (40 μL) | 200 μL |
|
|
| CLEC16A-NTAN1-20-GRAQ | 20 (40 μL) | 200 μL |
|
|
| CLEC16A-NTAN1-20-AQRE | 20 (40 μL) | 200 μL |
|
|
| CLEC16A-NTAN1-20-AQOR | 20 (40 μL) | 200 μL |
|
|
| CLEC16A-NTAN1-20-AQGO | 20 (40 μL) | 200 μL |
|
|
| CLEC16A-NTAN1-20-AQGR | 20 (40 μL) | 200 μL |
|
|
| CLEC16A-NTAN1-20-AQAQ | 20 (40 μL) | 200 μL |
|
CLEC16A Gene Summary
This gene encodes a member of the C-type lectin domain containing family. Single nucleotide polymorphisms in introns of this gene have been associated with diabetes mellitus, multiple sclerosis and rheumatoid arthritis. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Aug 2011]
Gene Name: C-type Lectin Domain Containing 16A
Chromosome: CHR16: 11038344 -11276046
Locus: 16p13.13
NTAN1 Gene Summary
The protein encoded by this gene functions in a step-wise process of protein degradation through the N-end rule pathway. This protein acts as a tertiary destabilizing enzyme that deamidates N-terminal L-Asn residues on proteins to produce N-terminal L-Asp. L-Asp substrates are subsequently conjugated to L-Arg, which is recognized by specific E3 ubiquitin ligases and targeted to the proteasome. Pseudogenes of this gene are located on the long arms of chromosomes 8, 10 and 12. Alternative splicing results in multiple transcript variants that encode different protein isoforms. [provided by RefSeq, Jul 2012]
Gene Name: N-terminal Asparagine Amidase
Chromosome: CHR16: 15131714 -15149833
Locus: 16p13.11
Gene Diseases
The CLEC16A NTAN1 Fusion has been associated with the following diseases:
| Disease Name |
|---|
| Uterine Corpus Endometrial Carcinoma |
FISH Probe Protocols
| Protocol, Procedure, or Form Name | Last Modified | Download |
|---|